W
W

Walgreens


Noticias

Walgreens accused of 'grossly inflated' fee bid in health plans' lawsuit

Walgreens accused of 'grossly inflated' fee bid in health plans' lawsuit By Mike Scarcella Sept 26 (Reuters) - Blue Cross and Blue Shield of Minnesota and other insurers have asked a U.S. judge to deny what they called a "grossly inflated" request for legal fees from national retail pharmacy chain Walgreens WBA.O arising from a dispute over evidence in a court case.
W

Rite Aid plans to shut down hundreds of stores in bankruptcy - WSJ

UPDATE 1-Rite Aid plans to shut down hundreds of stores in bankruptcy - WSJ Adds Rite Aid comment in paragraph 3 Sept 22 (Reuters) - Rite Aid RAD.N is negotiating with creditors over the terms of a bankruptcy plan that would include liquidating a substantial portion of its more than 2,100 drugstores, the Wall Street Journal reported on Friday, citing people familiar with the talks.
W

Rite Aid plans to shut down hundreds of stores in bankruptcy - WSJ

REFILE-Rite Aid plans to shut down hundreds of stores in bankruptcy - WSJ Corrects dateline to Sept 22 from Sept 23 Sept 22 (Reuters) - Rite Aid RAD.N is negotiating with creditors over the terms of a bankruptcy plan that would include liquidating a substantial portion of its more than 2,100 drugstores, the Wall Street Journal reported on Friday, citing people familiar with the talks.
W

Britain's Superdrug to stop selling single-use vapes

Britain's Superdrug to stop selling single-use vapes LONDON, Sept 22 (Reuters) - British pharmacy chain Superdrug will stop selling single-use vapes, the company announced on Friday, citing the environmental impact caused by their disposal and the popularity of the products among young people. Nearly five million disposable vapes are thrown away every week in Britain according to research by non-governmental organisation Material Focus and YouGov.
B
W

Walgreens hit with lawsuit after FDA warning over eyedrops

Walgreens hit with lawsuit after FDA warning over eyedrops By Diana Novak Jones Sept 21 (Reuters) - Walgreens was hit with a proposed class action in Florida federal court over claims it mislabeled eyedrops for treating pink eye and misled consumers into believing the product was safe and effective. The lawsuit , filed Wednesday, follows warning letters that the FDA sent to Illinois-based Walgreens and several other companies last week about selling and marketing eye care products that the agenc
W

U.S. STOCKS Knowles, RE/MAX Holdings, BioCryst Pharma

BUZZ-U.S. STOCKS ON THE MOVE-Knowles, RE/MAX Holdings, BioCryst Pharma Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes rose on Monday in choppy trading as energy stocks tracked higher crude oil prices, while investors awaited the Federal Reserve's interest rate decision later this week.
C
I
M
N
P
S
W
U
U
L
L
C
L
M

U.S. STOCKS Ralph Lauren, Lyft, natgas firms

BUZZ-U.S. STOCKS ON THE MOVE-Ralph Lauren, Lyft, natgas firms Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were subdued in choppy trading on Monday as some megacap and chip stocks declined in the run-up to the Federal Reserve's interest rate decision later this week.
B
C
D
I
M
N
P
S
W
R
U
U
L
L
C
L
M

Evercore ISI sees limited impact on drug stores after FDA panel vote on decongestant

BUZZ-Evercore ISI sees limited impact on drug stores after FDA panel vote on decongestant ** Evercore ISI sees limited impact on drug stores like Walgreens Boots Alliance WBA.O and CVS Health Corp CVS.N from FDA panel's vote against the effectiveness of oral over-the-counter (OTC) medicines made with phenylephrine, an ingredient widely used in cold and cough syrups ** The FDA, last week, said it would seek public opinion before finalizing its decision to remove it from the agency's list of ingre
W

UK regulator approves Moderna's updated COVID vaccine

UPDATE 1-UK regulator approves Moderna's updated COVID vaccine Adds background and details throughout Sept 15 (Reuters) - The UK drug regulator said on Friday it has approved an updated COVID-19 vaccine by Moderna MRNA.O , making it the second shot to be used in the country's vaccination campaign this autumn. The updated shot, branded Spikevax, to target the XBB.1.5 variant of Omicron, is indicated for use in adults and children aged 6 months and above.
P
W

J&J unit, P&G, Walgreens misled consumers about decongestants--lawsuits

UPDATE 3-J&J unit, P&G, Walgreens misled consumers about decongestants--lawsuits In Sept 14 story, adds comments from Johnson & Johnson, Kenvue, paragraphs 10-11; recasts first paragraph By Jonathan Stempel Sept 14 (Reuters) - Procter & Gamble PG.N , Walgreens WBA.O and Johnson & Johnson's JNJ.N former consumer business are among several companies accused in lawsuits of deceiving consumers about cold medicines containing an ingredient that a unanimous U.S.
G
W

EU regulatory panel backs Moderna's updated COVID shot

UPDATE 2-EU regulatory panel backs Moderna's updated COVID shot Adds background and details in paragraphs 3 to 6 Sept 14 (Reuters) - The European regulator's advisory panel on Thursday recommended authorising an updated COVID-19 vaccine from Moderna MRNA.O , putting it on track to become the second shot to be used in the EU countries' vaccination campaign this autumn.
P
W

US pharmacy chains gear up to administer updated COVID shots

UPDATE 1-US pharmacy chains gear up to administer updated COVID shots Adds detail on delivery beginning in some locations in paragraph 2 Sept 13 (Reuters) - U.S. drugstore chains CVS Health CVS.N and Walgreens Boots Alliance WBA.O said on Wednesday that updated COVID-19 vaccines would be available at their stores as soon as this week. S hots were being delivered in some locations on Wednesday, including at a Northwell Health facility in New York.
P
W

US pharmacy chains gear up to administer updated COVID shots

US pharmacy chains gear up to administer updated COVID shots Sept 13 (Reuters) - Drugstore chains CVS Health CVS.N and Walgreens Boots Alliance WBA.O said on Wednesday that updated COVID-19 vaccines would be available at their stores as soon as this week. The U.S. Centers for Disease Control and Prevention (CDC) director on Tuesday signed off on broad use of updated COVID-19 vaccines , arming a push to align the next round of shots more closely with the circulating variant of the virus, much lik
P
W

Walgreens Says Covid-19 Vaccines Will Continue To Be Available At No Cost To The Public

BRIEF-Walgreens Says Covid-19 Vaccines Will Continue To Be Available At No Cost To The Public Sept 13 (Reuters) - Walgreens Boots Alliance Inc WBA.O : WALGREENS - COVID-19 VACCINES WILL CONTINUE TO BE AVAILABLE AT NO COST TO THE PUBLIC WALGREENS - HAVE RECEIVED AUTHORIZATION FROM CDC THAT WILL ALLOW US TO IMMEDIATELY SERVE PATIENTS WHO QUALIFY FOR
W

Walgreens Says Individuals To Be Able To Schedule Covid-19 Vaccine Appointments Immediately, With Appointments Starting Nationwide On Monday, Sept 18

BRIEF-Walgreens Says Individuals To Be Able To Schedule Covid-19 Vaccine Appointments Immediately, With Appointments Starting Nationwide On Monday, Sept 18 Sept 13 (Reuters) - Walgreens Boots Alliance Inc WBA.O : WALGREENS - INDIVIDUALS TO BE ABLE TO SCHEDULE COVID-19 VACCINE APPOINTMENTS IMMEDIATELY, WITH APPOINTMENTS STARTING NATIONWIDE ON MONDAY
W

Pharmacies' appeal of $650 mln opioid judgment heads to Ohio top court

Pharmacies' appeal of $650 mln opioid judgment heads to Ohio top court 6th Circuit certifies question regarding public nuisance law to Ohio Supreme Court Opioid case was first against pharmacies to go to trial By Nate Raymond Sept 12 (Reuters) - A federal appeals court weighing whether to uphold a $650 million judgment against pharmacy operators CVS CVS.N , Walmart WMT.N and Walgreens WBA.O for fueling the opioid epidemic in parts of Ohio has asked the state's highest court to weigh in first.
W

FDA Issues Warning Letters To Firms Marketing Unapproved Eye Products

BRIEF-FDA Issues Warning Letters To Firms Marketing Unapproved Eye Products Sept 12 (Reuters) - FDA: FDA ISSUES WARNING LETTERS TO FIRMS MARKETING UNAPPROVED EYE PRODUCTS FDA: ISSUED WARNING LETTERS TO BOIRON, CVS HEALTH, DR VITAMIN SOLUTIONS, NATURAL OPHTHALMICS, OCLUMED, SIMILASAN AG/SIMILASAN USA, TRP COMPANY, WALGREENS FDA - HAS PLACED SOME OF THESE COMPANIES ON IMPORT ALERT TO HELP STOP THEIR PRODUCTS FROM ENTERING THE U.S.
W

Nasdaq top and bottom performing stocks at about 12:04 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 12:04 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Walgreens Boots Alliance Inc WBA.OQ +3.5% Diamondback Energy Inc FANG.OQ +3% PayPal Holdings Inc PYPL.OQ +2.4% PDD Holdings Inc PDD.OQ +2.4% Cintas Corp CTAS.OQ +2.2% Bottom Performers Percent Change Illumina Inc ILMN.OQ -2.8% Datadog Inc DDOG.OQ -2.5% Adobe Inc ADBE.OQ -2.5% Autodesk Inc ADSK.OQ -2.5% Align Technology Inc ALGN.OQ -2.3% The Nasdaq 100 .NDX lost 101.78 points, or 0
A
A
C
I
P
W
U
A
D
P

S&P 500 top and bottom performing stocks at about 12:01 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:01 p.m. EDT S&P 500 .SPX Top Performers Percent Change Zions Bancorporation NA ZION.OQ +7.6% PNC Financial Services Group Inc PNC.N +5.5% Westrock Co WRK.N +3.8% Occidental Petroleum Corp OXY.N +3.7% Walgreens Boots Alliance Inc WBA.OQ +3.6% Bottom Performers Percent Change Oracle Corp ORC
I
N
W
Z
U
W

FDA warns CVS, others against selling unapproved eye products

UPDATE 3-FDA warns CVS, others against selling unapproved eye products Adds Walgreens comment in paragraph 4 Sept 12 (Reuters) - The U.S. Food and Drug Administration on Tuesday warned eight companies, including pharmacy giants CVS Health Corp CVS.N and Walgreens Boots Alliance WBA.O , against manufacturing or marketing unapproved eye products. The eye products addressed in the FDA's letters to these companies are illegally marketed to treat conditions like conjunctivitis, cataract and glaucoma,
W



Condiciones

Activos populares

Descargo de responsabilidades: Cada una de las entidades de XM Group proporciona un servicio de solo ejecución y acceso a nuestra plataforma de trading online, permitiendo a una persona ver o usar el contenido disponible en o a través del sitio web, sin intención de cambiarlo ni ampliarlo. Dicho acceso y uso están sujetos en todo momento a: (i) Términos y Condiciones; (ii) Advertencias de riesgo; y (iii) Descargo completo de responsabilidades. Por lo tanto, dicho contenido se proporciona exclusivamente como información general. En particular, por favor tenga en cuenta que, los contenidos de nuestra plataforma de trading online no son ni solicitud ni una oferta para entrar a realizar transacciones en los mercados financieros. Operar en cualquier mercado financiero implica un nivel de riesgo significativo para su capital.

Todo el material publicado en nuestra plataforma de trading online tiene únicamente fines educativos/informativos y no contiene –y no debe considerarse que contenga– asesoramiento ni recomendaciones financieras, tributarias o de inversión, ni un registro de nuestros precios de trading, ni una oferta ni solicitud de transacción con instrumentos financieros ni promociones financieras no solicitadas.

Cualquier contenido de terceros, así como el contenido preparado por XM, como por ejemplo opiniones, noticias, investigaciones, análisis, precios, otras informaciones o enlaces a sitios de terceros que figuran en este sitio web se proporcionan “tal cual”, como comentarios generales del mercado y no constituyen un asesoramiento en materia de inversión. En la medida en que cualquier contenido se interprete como investigación de inversión, usted debe tener en cuenta y aceptar que dicho contenido no fue concebido ni elaborado de acuerdo con los requisitos legales diseñados para promover la independencia en materia de investigación de inversiones y, por tanto, se considera como una comunicación comercial en virtud de las leyes y regulaciones pertinentes. Por favor, asegúrese de haber leído y comprendido nuestro Aviso sobre investigación de inversión no independiente y advertencia de riesgo en relación con la información anterior, al que se puede acceder aquí.

Utilizamos cookies para ofrecerle una mejor experiencia en nuestra web. Conozca más o cambie sus ajustes de cookies.

Advertencia de riesgo: Los CFD son un producto difícil de comprender y la CNMV cree que no es adecuado para inversores minoristas dada su complejidad y riesgo. Por favor, lea y asegúrese de que comprende completamente nuestra Declaración de riesgos.